Sodium-glucose cotransporter inhibitors in type 2 diabetes: thinking beyond glucose lowering

被引：18
|
作者：
Neuen, Brendon L. [1 ]
Cherney, David Z. [2 ,3 ]
Jardine, Meg J. [1 ]
Perkovic, Vlado [1 ]
机构：
[1] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[2] Univ Toronto, Univ Hlth Network, Dept Med, Div Nephrol, Toronto, ON, Canada
[3] Univ Toronto, Univ Hlth Network, Dept Physiol, Div Nephrol, Toronto, ON, Canada
来源：
CANADIAN MEDICAL ASSOCIATION JOURNAL | 2019年 / 191卷 / 41期
基金：
英国医学研究理事会; 加拿大健康研究院;
关键词：
CARDIOVASCULAR OUTCOMES; KIDNEY-DISEASE; EMPAGLIFLOZIN; KETOACIDOSIS; MELLITUS; TRIALS; PEOPLE;
D O I：
10.1503/cmaj.190047
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E1128 / E1135
页数：8
相关论文
共 50 条
  • [21] Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus
    Ning Li
    Ruimin Chen
    Kewei Liu
    Clinical Drug Investigation, 2020, 40 : 991 - 1000
  • [22] Sodium-glucose cotransporter type 2 inhibitors and cardiac arrhythmias
    Manolis, Antonis A.
    Manolis, Theodora A.
    Melita, Helen
    Manolis, Antonis S.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2023, 33 (07) : 418 - 428
  • [23] Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
    Abdul-Ghani, Muhammad A.
    Norton, Luke
    DeFronzo, Ralph A.
    ENDOCRINE REVIEWS, 2011, 32 (04) : 515 - 531
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors and Amputations
    Clements, Jennifer N.
    JAMA INTERNAL MEDICINE, 2019, 179 (03) : 451 - 452
  • [25] Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
    Kawasoe, Shin
    Maruguchi, Yukiko
    Kajiya, Shoko
    Uenomachi, Hitoshi
    Miyata, Masaaki
    Kawasoe, Mariko
    Kubozono, Takuro
    Ohishi, Mitsuru
    BMC PHARMACOLOGY & TOXICOLOGY, 2017, 18
  • [26] Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
    Shin Kawasoe
    Yukiko Maruguchi
    Shoko Kajiya
    Hitoshi Uenomachi
    Masaaki Miyata
    Mariko Kawasoe
    Takuro Kubozono
    Mitsuru Ohishi
    BMC Pharmacology and Toxicology, 18
  • [27] Sodium-glucose cotransporter-2 inhibitors in patients without diabetes
    Fryml, Elise
    Lanktree, Matthew B.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2023, 195 (17) : E619 - E619
  • [28] The current role of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes mellitus management
    Xu, Bo
    Li, Shaoqian
    Kang, Bo
    Zhou, Jiecan
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [29] Cardiovascular and Renal Benefit of Sodium-Glucose Cotransporter Type 2 Inhibitors in Patients With Type 2 Diabetes
    Lam, Steven Ho Man
    Alam, Uazman
    Lip, Gregory Yoke Hong
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 223 : 183 - 185
  • [30] Use of Sodium-Glucose Cotransporter Type 2 Inhibitors in Older Adults with Type 2 Diabetes Mellitus
    Mikhail, Nasser
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (02) : 91 - 96
12345